Confirmed EHV Case At Gulfstream Park

Gulfstream Park confirmed Sunday a case of EHV on grounds in Barn 21.

“On Jan. 21, Gulfstream Park identified a horse who was displaying signs of EHV,” the track said in a statement. “That horse was immediately transferred to Rood & Riddle Veterinary Hospital in Wellington and the affected barn, barn 21 was placed in immediate quarantine. Testing was expedited through the Frederick Diagnostic Laboratory in Maryland which confirmed a positive EHV. Barn 21 remains in strict lockdown as per GSP protocols. One of the horses in quarantine was set to run in the Pegasus World Cup but was withdrawn prior to the post-position draw. We are awaiting further directive from the state veterinarian and will provide an update as soon as one is available.”

The post Confirmed EHV Case At Gulfstream Park appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Six Horses at Churchill Test Positive for EHV-1

Five additional horses stabled at Churchill Downs have tested positive for Equine Herpesvirus (EHV-1) after an initial case Tuesday of a horse showing symptoms consistent with the contagious disease. Churchill immediately quarantined the barn of the horse in question and 13 exposed horses also stabled in the barn were tested, with their confirmed positives returned Thursday morning. The initial horse, reportedly trained by Saffie Joseph, Jr., has also tested positive and is being treated at a Lexington-area clinic.

Several tracks across the country have banned shippers from Churchill and the Louisville track itself is restricting movement out of the backside. Churchill is working with the Kentucky Department of Agriculture to ensure maximum effectiveness of its health and safety protocols.

The five additional horses testing positive for EHV-1 are asymptomatic. EHV-1 is a relatively common viral disease that can be managed and is treatable. Clinical symptoms include fever, hind limb ataxia, and dripping urine.

The post Six Horses at Churchill Test Positive for EHV-1 appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Grayson-Jockey Club Foundation Seeking Applications For EHV Vaccine Research Development

Grayson-Jockey Club Research Foundation has issued a formal call for research applications focused on the development of a nucleic acid-based vaccine against equine herpes virus (EHV). Dr. John Ballantyne and Fargo-Moorhead Area Foundation have committed $2 million to fund this research.

“We are so grateful to Dr. Ballantyne for his generosity in supporting efforts to address EHV, a disease that affects all horses,” said Dell Hancock, chair of the foundation. “This gift will enable Grayson to continue its commitment to funding critical research for horses, and our research advisory committee looks forward to seeing what proposals are submitted.”

“As a horse owner with a biotechnology background, I recognize the danger of EHV and see the potential for nucleic acid-based vaccines for combating this disease,” said Dr. Ballantyne. “I am proud to work with Grayson to support EHV research.”

Grayson is interested in research proposals focused on EHV-1, EHV-3, and EHV-4, with a multivalent or pan-valent approach. Researchers must have the ability to conduct an in vivo proof of principle of efficacy in the equine model in-house or through collaboration. Applications from established equine investigators collaborating with experts from other fields (e.g., human vaccinologists) are strongly encouraged. It is anticipated that this research will span three to four years and possibly multiple projects.

Grant applications are due October 1, 2022, and can be submitted at grayson-jockeyclub.org.

Grayson-Jockey Club Research Foundation is traditionally the nation's leading source of private funding for equine medical research that benefits all breeds of horses. Since 1983, the foundation has provided more than $30.6 million to fund 397 projects at 45 universities in North America and overseas. Additional information about the foundation is available atgrayson-jockeyclub.org.

The post Grayson-Jockey Club Foundation Seeking Applications For EHV Vaccine Research Development appeared first on Horse Racing News | Paulick Report.

Source of original post

Grayson-Jockey Club Calls for Research into EHV Vaccine

Edited press release

Grayson-Jockey Club Research Foundation has issued a formal call for research applications focused on the development of a nucleic acid-based vaccine against equine herpes virus (EHV). Dr. John Ballantyne and Fargo-Moorhead Area Foundation have committed $2 million to fund this research.

“We are so grateful to Dr. Ballantyne for his generosity in supporting efforts to address EHV, a disease that affects all horses,” said Dell Hancock, chair of the foundation. “This gift will enable Grayson to continue its commitment to funding critical research for horses, and our research advisory committee looks forward to seeing what proposals are submitted.”

“As a horse owner with a biotechnology background, I recognize the danger of EHV and see the potential for nucleic acid-based vaccines for combating this disease,” said Dr. Ballantyne. “I am proud to work with Grayson to support EHV research.”

Grayson is interested in research proposals focused on EHV-1, EHV-3, and EHV-4, with a multivalent or pan-valent approach. Researchers must have the ability to conduct an in vivo proof of principle of efficacy in the equine model in-house or through collaboration. Applications from established equine investigators collaborating with experts from other fields (e.g., human vaccinologists) are strongly encouraged. It is anticipated that this research will span three to four years and possibly multiple projects.

Grant applications are due October 1, 2022, and can be submitted at grayson-jockeyclub.org.

Grayson-Jockey Club Research Foundation is traditionally the nation's leading source of private funding for equine medical research that benefits all breeds of horses. Since 1983, the foundation has provided more than $30.6 million to fund 397 projects at 45 universities in North America and overseas.

The post Grayson-Jockey Club Calls for Research into EHV Vaccine appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Verified by MonsterInsights